Article
Novel Antifungals and <em>Aspergillus</em> Section <em>Terrei</em> with Potpourri Susceptibility Profiles to Conventional Antifungals
2023-05-17
Abstract excerpt
The epidemiology of invasive fungal infections (IFIs) is currently changing, driven by aggressive immunosuppressive therapy, leading to an expanded spectrum of patients at risk of IFIs. Aspergillosis is a leading cause of IFIs, which usually affects immunocompromised patients. There is a limited number of antifungal medications available for treating IFIs and their effectiveness is often hindered by rising resista...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 93ac9b8b-8453-5ea3-9a78-a05da3fe2f69
- DOI
- 10.20944/preprints202305.1236.v1
